Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Abstract Introduction Infliximab infusion generally occurs in 2–4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug. Objective To evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction wa...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2018-08-01
|
| シリーズ: | Advances in Rheumatology |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s42358-018-0016-x |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|